IOVANCE BIOTHERAPEUTICS, INC. Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31)
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) of $0 for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-10-23.
Discontinued › Notes
us-gaap:IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments · last filed 2013-10-23
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in fair value of derivative instruments, not designated as hedging instruments (deprecated 2013-01-31) for the quarter ending 2013-03-31 was $0.00.
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in fair value of derivative instruments, not designated as hedging instruments (deprecated 2013-01-31) for the quarter ending 2012-12-31 was $7.66M.
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in fair value of derivative instruments, not designated as hedging instruments (deprecated 2013-01-31) for the quarter ending 2012-09-30 was $1.60M, a 54.99% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in fair value of derivative instruments, not designated as hedging instruments (deprecated 2013-01-31) for the quarter ending 2012-06-30 was $1.93M.
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in fair value of derivative instruments, not designated as hedging instruments (deprecated 2013-01-31) for fiscal 2012 was $8.64M, a 441.04% increase from fiscal 2011.
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in fair value of derivative instruments, not designated as hedging instruments (deprecated 2013-01-31) for fiscal 2011 was $1.60M.
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in fair value of derivative instruments, not designated as hedging instruments (deprecated 2013-01-31) for fiscal 2010 was -$229.23K.
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in fair value of derivative instruments, not designated as hedging instruments (deprecated 2013-01-31) for fiscal 2009 was $0.00.
| Period end | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 3 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 6 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 9 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 12 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 45 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 48 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 51 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 54 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 57 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 60 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 63 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 66 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-03-31 | $0.00 10-Q · filed 2013-10-23 | $7.66M derived: sum of 2 quarters · filed 2013-10-23 | $9.26M derived: sum of 3 quarters · filed 2013-10-23 | $11.18M derived: sum of 4 quarters · filed 2013-10-23 | $10.00M 10-Q · filed 2013-10-23 | |||||||
| 2012-12-31 | $7.66M derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-23 | $9.26M derived: sum of 2 quarters · filed 2013-09-23 | $11.18M derived: sum of 3 quarters · filed 2013-09-23 | $8.64M 10-K · filed 2013-09-23 | $10.00M 10-K · filed 2013-09-23 | |||||||
| 2012-09-30 | $1.60M 10-Q · filed 2013-01-25 | $3.52M derived: sum of 2 quarters · filed 2013-01-25 | $975.70K 10-Q · filed 2013-01-25 | -$669.71K derived: sum of 4 quarters · filed 2013-10-23 | $2.34M 10-Q · filed 2013-01-25 | |||||||
| 2012-06-30 | $1.93M 10-Q/A · filed 2012-09-10 | -$620.24K 10-Q/A · filed 2012-09-10 | -$2.27M derived: sum of 3 quarters · filed 2013-10-23 | $1.28M derived: sum of 4 quarters · filed 2013-10-23 | $746.57K 10-Q/A · filed 2012-09-10 | |||||||
| 2012-03-31 | -$2.55M 10-Q · filed 2013-10-23 | -$4.19M derived: sum of 2 quarters · filed 2013-10-23 | -$647.44K derived: sum of 3 quarters · filed 2013-10-23 | -$1.05M derived: sum of 4 quarters · filed 2013-10-23 | -$1.18M 10-Q · filed 2012-05-15 | |||||||
| 2011-12-31 | -$1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-23 | $1.90M derived: sum of 2 quarters · filed 2013-09-23 | $1.50M derived: sum of 3 quarters · filed 2013-09-23 | $1.60M 10-K · filed 2013-09-23 | $1.37M 10-K · filed 2012-03-30 | |||||||
| 2011-09-30 | $3.55M 10-Q · filed 2013-01-25 | $3.15M derived: sum of 2 quarters · filed 2013-01-25 | $3.24M 10-Q · filed 2013-01-25 | $3.00M derived: sum of 4 quarters · filed 2013-01-25 | $3.01M 10-Q · filed 2011-11-21 | |||||||
| 2011-06-30 | -$398.56K 10-Q/A · filed 2012-09-10 | -$304.60K 10-Q/A · filed 2012-09-10 | -$550.45K derived: sum of 3 quarters · filed 2012-09-10 | -$533.83K derived: sum of 4 quarters · filed 2012-09-10 | -$533.83K 10-Q/A · filed 2011-09-01 | |||||||
| 2011-03-31 | $93.95K 10-Q · filed 2012-05-15 | -$151.89K derived: sum of 2 quarters · filed 2012-05-15 | -$135.27K derived: sum of 3 quarters · filed 2012-05-15 | -$135.27K derived: sum of 4 quarters · filed 2012-05-15 | ||||||||
| 2010-12-31 | -$245.84K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | -$229.23K derived: sum of 2 quarters · filed 2012-03-30 | -$229.23K derived: sum of 3 quarters · filed 2012-03-30 | -$229.23K 10-K · filed 2012-03-30 | ||||||||
| 2010-09-30 | $16.62K 10-Q · filed 2011-11-21 | $16.62K derived: sum of 2 quarters · filed 2011-11-21 | $16.62K 10-Q · filed 2011-11-21 | |||||||||
| 2010-06-30 | $0.00 10-Q/A · filed 2011-09-01 | $0.00 10-Q/A · filed 2011-09-01 | ||||||||||
| 2009-12-31 | $0.00 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |